NCT03686397View on ClinicalTrials.gov

SVT-15652 Otic Solution for the Treatment of Otomycosis.

PHASE3CompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

June 9, 2020

Primary Completion Date

October 19, 2021

Study Completion Date

October 19, 2021

Conditions
Otomycosis
Interventions
DRUG

SVT-15652

1 vial twice daily

DRUG

Placebo

1 vial twice daily

Trial Locations (1)

Unknown

Hospital Clinic, Barcelona

Sponsors

Lead Sponsor

Salvat
All Listed Sponsors
lead

Salvat

INDUSTRY

NCT03686397 - SVT-15652 Otic Solution for the Treatment of Otomycosis. | Biotech Hunter | Biotech Hunter